PCDHB18P: A Potential Drug Target and Biomarker (G54660)

Target Name: PCDHB18P

NCBI ID: G54660

PCDHB18P

Other Name(s): Protocadherin beta 18 pseudogene | PCDH-psi2 | protocadherin beta 18 pseudogene | PCDHB18

PCDHB18P: A Potential Drug Target and Biomarker

Personalized medicine has emerged as a promising approach to healthcare, allowing for the tailored treatment of patients based on their individual characteristics. One of the key challenges in personalized medicine is the development of biomarkers, which are diagnostic or predictive indicators that can be used to selectively target diseases or conditions. One promising biomarker that has been identified is PCDHB18P, a gene expression profile that has been associated with various diseases, including cancer, cardiovascular disease, and neurological disorders.

PCDHB18P is a gene that encodes a protein known as protamineurea heat shock protein (PmHSP). PmHSP is a heat-induced protein that has been shown to play a role in various cellular processes, including stress response, DNA damage repair, and inflammation. In addition, PmHSP has also been associated with cancer progression and the development of neurodegenerative diseases.

Studies have shown that PCDHB18P is expressed in various tissues and cells, including cancer cells, immune cells, and brain cells. Additionally, overexpression of PCDHB18P has been shown to promote the growth and survival of cancer cells, suggesting that it may be a potential drug target.

In addition to its potential as a drug target, PCDHB18P has also been identified as a potential biomarker for several diseases. For example, PCDHB18P has been shown to be overexpressed in individuals with neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, high expression of PCDHB18P has also been associated with an increased risk of cancer, including breast and ovarian cancer.

In conclusion, PCDHB18P is a promising biomarker and drug target that has been associated with various diseases. Further research is needed to fully understand its role in personalized medicine and to develop effective treatments.

Protein Name: Protocadherin Beta 18 Pseudogene

Functions: Potential calcium-dependent cell-adhesion protein

The "PCDHB18P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB18P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets